NCT03257995 Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Status COMPLETED Phase PHASE2
NCT03257358 A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod Status COMPLETED Phase PHASE4
NCT03249714 Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab Status COMPLETED Phase PHASE2
NCT03242928 Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD) Status COMPLETED Phase PHASE2
NCT03240393 Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) Status WITHDRAWN Phase PHASE2
NCT03232892 Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03226392 Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT03215758 Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT03207867 A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT03207334 iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004) Status WITHDRAWN Phase PHASE2
NCT03205150 Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients Status COMPLETED Phase PHASE2
NCT03203850 Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) Status TERMINATED Phase PHASE2
NCT03200717 Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment Status COMPLETED Phase PHASE2
NCT03198767 Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066 Status COMPLETED Phase PHASE2
NCT03194776 Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication Status COMPLETED Phase PHASE2
NCT03176264 PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer Status TERMINATED Phase PHASE1
NCT03176238 Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT03172936 Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas Status TERMINATED Phase PHASE1